Latest Biotech News

Recent clinical and regulatory developments signal progress in drug approval and therapeutic innovation. Firsekibart, an anti-IL-1β monoclonal antibody, demonstrates safety in a Phase 1 trial in...

Innovative research in environmental and agricultural biotechnology reveals impactful ecological and production insights. Scientists have engineered a yeast-based bee food supplement that delivers...

Researchers have combined artificial intelligence with molecular pharmacology to identify Bufalin as a novel molecular glue degrader targeting estrogen receptor alpha (ERα), a key driver in...

New clinical investigations have shed light on the safety and effectiveness of infliximab biosimilar CT-P13 in rheumatic diseases and demonstrated interchangeability between CT-P17 and reference...

Artificial intelligence is increasingly revolutionizing oncologic diagnostics. Notably, Uppsala University developed AI capable of detecting prostate cancer cases missed by pathologists, enhancing...

Recent studies have identified critical molecular markers impacting cancer detection and progression. Circ_0000847 RNA was found to promote colorectal cancer invasion through IGF2BP2 binding,...

Innovations in artificial intelligence are rapidly transforming drug discovery and genome engineering. Recent reports highlight AI/machine learning applications optimizing genome editing outcomes...

A pioneering personalized liquid biopsy assay, MRD4U, has been developed to track pediatric central nervous system tumors with exceptional sensitivity. This genomic assay enables early detection...

New developments in electrochemistry and materials science are enhancing energy storage and sensing technologies. Innovations include defect-engineered doped BiFeO3 nanoparticles improving...

Innovative immunotherapy research has pinpointed new molecular regulators that could reshape cancer treatment. T regulatory cells expressing a shortened FOXP3 isoform bolster cytotoxic T cell...

Significant regulatory developments are shaping the biotech sector. The FDA has initiated daily publishing of drug adverse event reports to improve transparency and post-market surveillance....

Kriya Therapeutics raised $313 million in a significant funding round to support its pipeline of one-time gene therapies targeting ophthalmic, metabolic, and neurological diseases. This financing...

Recent innovations in artificial intelligence are reshaping medical imaging and diagnostics across oncology and neurology. Uppsala University researchers developed an AI model detecting prostate...

Multiple studies unveil innovative therapeutic targets and biomarkers shaping future cancer treatments. B3GNT5 has been identified as a regulator of EMT, MET, and chemoresistance mechanisms,...

The biopharma sector exhibits robust financing activity and strategic leadership shifts. Kriya Therapeutics closed a massive $313 million funding round to advance gene therapies targeting chronic...

Cutting-edge research offers new insights and therapeutic avenues for neurodegenerative diseases. A novel brain-shuttled antibody targeting alpha-synuclein aggregates shows promise for treating...

Artificial intelligence and machine learning continue to accelerate biomedical innovation in drug discovery. MIT researchers showcased a generative AI model capable of proposing novel antibiotic...

Recent studies underscore intricate climate-environment-health interactions with broad implications. Global decarbonization efforts correlate with unseasonal land cover changes worldwide,...

Emerging research reveals novel mechanisms influencing immunotherapy and tumor microenvironments. A morpholino oligonucleotide reprogramming regulatory T cells to express a FOXP3 variant enhances...

Significant progress has been made in infectious and rare disease treatments. Ionis Pharmaceuticals secured FDA approval for Dawnzera, a first-in-class antisense drug to prevent hereditary...